Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The fourth-generation Calcium channel blocker: cilnidipine Chandra KS; Ramesh GIndian Heart J 2013[Dec]; 65 (6): 691-5Several classes of antihypertensive agents have been in clinical use, including diuretics, alpha-blockers, beta-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin II type 1 receptor blockers (ARB), and organic calcium channel blockers (CCBs). All these drugs are being currently used in the treatment of Hypertension & various disease conditions of the heart either alone or in combination. Cilnidipine is a new antihypertensive drug distinguished from other L-type Ca(2+) channel blockers or even other antihypertensives, which will be useful for selection of antihypertensive drugs according to the pathophysiological condition of a patient.|Adrenergic beta-Antagonists/pharmacology/therapeutic use[MESH]|Angiotensin-Converting Enzyme Inhibitors/pharmacology/therapeutic use[MESH]|Antihypertensive Agents/pharmacology/*therapeutic use[MESH]|Calcium Channel Blockers/pharmacology/*therapeutic use[MESH]|Dihydropyridines/pharmacology/*therapeutic use[MESH]|Female[MESH]|Humans[MESH]|Hypertension/diagnosis/*drug therapy/epidemiology[MESH]|Male[MESH]|Patient Selection[MESH]|Sensitivity and Specificity[MESH]|Severity of Illness Index[MESH]|Treatment Outcome[MESH] |
